APA
Johnston H. E., Carter M. J., Larrayoz M., Clarke J., Garbis S. D., Oscier D., Strefford J. C., Steele A. J., Walewska R. & Cragg M. S. (20190213). Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation. : Molecular & cellular proteomics : MCP.
Chicago
Johnston Harvey E, Carter Matthew J, Larrayoz Marta, Clarke James, Garbis Spiro D, Oscier David, Strefford Jonathan C, Steele Andrew J, Walewska Renata and Cragg Mark S. 20190213. Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation. : Molecular & cellular proteomics : MCP.
Harvard
Johnston H. E., Carter M. J., Larrayoz M., Clarke J., Garbis S. D., Oscier D., Strefford J. C., Steele A. J., Walewska R. and Cragg M. S. (20190213). Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation. : Molecular & cellular proteomics : MCP.
MLA
Johnston Harvey E, Carter Matthew J, Larrayoz Marta, Clarke James, Garbis Spiro D, Oscier David, Strefford Jonathan C, Steele Andrew J, Walewska Renata and Cragg Mark S. Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation. : Molecular & cellular proteomics : MCP. 20190213.